In perfused rat liver tissue, vasopressin changes how the liver releases glucose when insulin and adrenal hormones are present, but it does not change how the liver converts glucose or lactate into fatty acids.
See the scientific wording
Vasopressin modulates hepatic glucose release in the presence of insulin and adrenal hormones, but does not affect fatty acid synthesis from glucose or lactate in perfused rat liver tissue.
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
The control by vasopressin of carbohydrate and lipid metabolism in the perfused rat liver.
Case-Control StudyAnimal
In rat livers, vasopressin makes the liver release more sugar but doesn’t seem to change how it turns sugar or lactate into fat — so it’s only messing with sugar, not fat.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Vasopressin binds to liver cells and triggers a signal that breaks down stored sugar into glucose and releases it into the blood. This only works fully when adrenal hormones are present to keep the sugar-breaking machinery active. Vasopressin does not change how the liver turns sugar or lactate into fat.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In perfused rat liver tissue, vasopressin changes how the liver releases glucose when insulin and adrenal hormones are present, but it does not change how the liver converts glucose or lactate into fatty acids.
Mechanism
1 studyVasopressin tells the liver to break down its stored sugar and release it into the blood, but only if adrenal hormones are present to keep the sugar-breaking tools working. It does nothing to the liver’s ability to turn sugar or lactate into fat.
Vasopressin binds to liver cells and triggers a signal that breaks down stored sugar into glucose and releases it into the blood. This only works fully when adrenal hormones are present to keep the sugar-breaking machinery active. Vasopressin does not change how the liver turns sugar or lactate into fat.
Vasopressin binds to V1 receptors on hepatocytes.
Receptor activation triggers intracellular calcium mobilization and protein kinase C activation, initiating glycogenolysis.
Adrenal-derived glucocorticoids maintain the expression and activity of glycogenolytic enzymes, enabling full glucose release.
Glucose is released from hepatocytes into the perfusate as a direct result of glycogen breakdown.
Vasopressin does not alter the enzymatic pathways converting glucose or lactate into fatty acids.
Evidence from Studies
Supporting (1)
Community contributions welcome
The control by vasopressin of carbohydrate and lipid metabolism in the perfused rat liver.
In rat livers, vasopressin makes the liver release more sugar but doesn’t seem to change how it turns sugar or lactate into fat — so it’s only messing with sugar, not fat.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Vasopressin's Effects on Hepatic Glucose and Lipid Metabolism in Perfused Liver Models
Systematic review and meta-analysis of all peer-reviewed studies using perfused rat liver tissue, comparing vasopressin exposure with and without insulin and adrenal hormones, measuring glucose release and fatty acid synthesis from glucose or lactate.
Controlled Perfusion Study of Vasopressin, Insulin, and Adrenal Hormones on Hepatic Glucose and Fatty Acid Metabolism in Rats
Perfused rat liver preparations exposed to vasopressin alone, vasopressin with insulin, vasopressin with adrenal hormones, and combinations, measuring glucose output and fatty acid synthesis from glucose and lactate over 60–120 minutes.
Hepatocyte Culture Study of Vasopressin's Impact on Gluconeogenesis and Lipogenesis Pathways with Hormonal Modulators
Primary rat hepatocytes treated with vasopressin, insulin, and adrenal hormones individually and in combination, measuring glucose production and fatty acid synthesis from labeled glucose and lactate over 24 hours.
Case Report of Altered Hepatic Metabolism in a Rat Model Following Vasopressin Infusion with Hormonal Manipulation
Single perfused rat liver experiment reporting glucose release and fatty acid synthesis outcomes after vasopressin infusion with defined insulin and adrenal hormone concentrations.